measuregroup/AID1568829

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440122694_AID1568829_PMID31229876_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103164209_AID1568829_PMID31229876_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440161383_AID1568829_PMID31229876_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103165719_AID1568829_PMID31229876_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440155162_AID1568829_PMID31229876_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103756096_AID1568829_PMID31229876_VALUE3
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50406
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Antagonist activity at recombinant human 5HT6 receptor expressed in CHOK1 cells co-expressing Galpha16/aequorin assessed as reduction in serotonin-induced calcium mobilization flux preincubated for 30 mins followed by serotonin addition in presence of coelenterazine h by luminescence assay
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103165719 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440161383 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440122694 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440155162 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103756096 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103164209
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1568829

Total number of triples: 17.